Document is current
Any future updates will be listed below
-
Authors
Agdashian, David
ElGindi, Mei
Xie, Changqing
Sandhu, Milan
Pratt, Drew
Kleiner, David E.
Figg, William D.
Rytlewski, Julie A.
Sanders, Catherine
Yusko, Erik C.
Wood, Bradford
Venzon, David
Brar, Gagandeep
Duffy, Austin G.
Greten, Tim F. https://orcid.org/0000-0002-0806-2535
Korangy, Firouzeh
-
Funding
Funding for this research was provided by:
National Cancer Institute (ZIA BC 011343)
- License Information
-
More Information
Article History
Received: 28 June 2018
Accepted: 6 January 2019
First Online: 28 January 2019
Compliance with ethical standards
:
: The study with the ClinicalTrials.gov identifier NCT01853618 was approved by the NCI Institutional Review Board (IRB) on 4/10/2013.
: All patients provided written informed consent before enrollment onto the study trial to receive treatment. Patients also provided written informed consent prior to procuring biopsied tissue and blood samples to conduct research analysis understanding the deidentified data collected would be used for publication purposes.
: Julie A. Rytlewski, Catherine Sanders and Erik C. Yusko all have equity and employment with Adaptive Biotechnologies. All other authors declare that they have no conflict of interest.
